Purchase Order 7571MN26P00043
Award Date 6/18/26
Potential Completion Date 7/18/26
Potential Value $120K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of State's Office of the Assistant Secretary for Administration awarded a $174,976 firm fixed-price purchase order to Valneva USA, Inc. (doing business as Intercell USA Inc.) for Japanese encephalitis vaccine on January 12, 2026. The contract, designated as a Total Small Business set-aside, calls for delivery to Bethesda, Maryland, with an ultimate completion date of January 12, 2026. Valneva USA, a subsidiary of French vaccine manufacturer Valneva SE, is a established...
- This is a $16,016,000.00 firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE. The contract is for the supply of the Japanese encephalitis vaccine IXIARO. This delivery order is part of a larger $48,025,600 indefinite delivery contract awarded to Valneva USA in September 2023, which supports the Department of Defense's medical...
- This is a firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, to Valneva USA, Inc. (dba Intercell USA Inc.), a foreign-owned for-profit organization. The $18,760.75 order is for the supply of the Japanese encephalitis vaccine IXIARO, which is being delivered against Valneva USA's General Services Administration (GSA) Schedule 61-IB contract for Pharmaceuticals and Drugs. This order has an ultimate completion date of...
- This is a firm fixed-price delivery order awarded by the Bureau of Medical Services, a civilian agency, to Valneva USA, Inc. (doing business as Intercell USA Inc.), a foreign-owned for-profit organization. The order is for the supply of the IXIARO Japanese encephalitis vaccine, with an ultimate completion date of September 30, 2024 and a ceiling value of $56,646.00. The contract was issued under the General Services Administration (GSA) Pharmaceutical and Drugs Federal Supply Schedule...
- Valneva USA, Inc., a specialty vaccine manufacturer headquartered in Bethesda, Maryland and subsidiary of French-based Valneva SE, was awarded a delivery order valued at $8.25 million on October 23, 2025, for Japanese encephalitis vaccine (IXIARO) to support the Medical Supply Chain program within the Defense Department. This firm fixed-price delivery order, with an ultimate completion date of December 5, 2025, represents performance at Valneva USA's Bethesda facility and carries no set-aside...
- The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed-price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.) for the Japanese Encephalitis Vaccine (IXIARO). The $237,264.00 contract, which has no set-aside designation, will be performed in Bethesda, Maryland and runs through April 19, 2024. Valneva USA, Inc. is a subsidiary of the specialty vaccine company Valneva SE, which develops and manufactures vaccines to address...
- This is a firm fixed-price delivery order contract awarded to Valneva USA, Inc., a foreign-owned, for-profit organization based in Bethesda, Maryland. The contract, valued at $5,883,494.40, is for the delivery of the Japanese encephalitis vaccine IXIARO to support the Medical Supply Chain, a Defense agency. The contract does not have a set-aside designation and is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Valneva USA, Inc. is the prime contractor responsible...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Valneva USA, Inc. - doing business as Intercell USA Inc. - to provide the IXIARO Japanese encephalitis virus vaccine. The $247,897.00 firm fixed price delivery order was placed against Valneva's GSA Schedule 61 contract for Pharmaceuticals and Drugs. The delivery order has a completion date of March 15, 2022 and was awarded on February 15, 2022. This order is part of Valneva's broader...
- Valneva USA, Inc. (doing business as Intercell USA Inc.) was awarded a $710,457 firm fixed-price delivery order by the Department of Veterans Affairs, Veterans Integrated Service Network 12, on November 1, 2025, for the supply of Japanese Encephalitis Virus Vaccine IXIARO. The contract is scheduled for completion by September 30, 2026, with performance taking place in Bethesda, Maryland. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order to Valneva USA, Inc. - doing business as Intercell USA Inc. - to supply JAPANESE ENCEPHELITIS VIRUS VACCINE INJ., SUSP IXIARO 6MCG NDC: 42515-0002-01. The $186,050.00 contract has a completion date of November 8, 2019 and was issued under Valneva USA's existing GSA Schedule 61-IB Pharmaceuticals and Drugs contract. This order was not set aside and is one of multiple federal contracts...
The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded a purchase order to Valneva USA, Inc. for Japanese encephalitis vaccine (IXIARO) valued at $120,296.00 on June 18, 2026, designated as a Total Small Business set-aside. Place of performance is Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of July 18, 2026.
Generated 6/19/26, 9:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $170.0k | 6/17/26 | |
| P00001 | Funding Only Action | ($50k) | 6/17/26 |